These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16652140)

  • 1. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts.
    Dunne J; Cullmann C; Ritter M; Soria NM; Drescher B; Debernardi S; Skoulakis S; Hartmann O; Krause M; Krauter J; Neubauer A; Young BD; Heidenreich O
    Oncogene; 2006 Oct; 25(45):6067-78. PubMed ID: 16652140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.
    Heidenreich O; Krauter J; Riehle H; Hadwiger P; John M; Heil G; Vornlocher HP; Nordheim A
    Blood; 2003 Apr; 101(8):3157-63. PubMed ID: 12480707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
    Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
    Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients.
    Krauter J; Wattjes MP; Nagel S; Heidenreich O; Krug U; Kafert S; Bunjes D; Bergmann L; Ganser A; Heil G
    Br J Haematol; 1999 Oct; 107(1):80-5. PubMed ID: 10520027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF.
    Shimada H; Ichikawa H; Nakamura S; Katsu R; Iwasa M; Kitabayashi I; Ohki M
    Blood; 2000 Jul; 96(2):655-63. PubMed ID: 10887131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript.
    Miyoshi H; Kozu T; Shimizu K; Enomoto K; Maseki N; Kaneko Y; Kamada N; Ohki M
    EMBO J; 1993 Jul; 12(7):2715-21. PubMed ID: 8334990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of target by siRNA: designing of AML1-MTG8 fusion mRNA-specific siRNA sequences.
    Kasashima K; Sakota E; Kozu T
    Biochimie; 2004; 86(9-10):713-21. PubMed ID: 15556282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro catalytic activities of DNA/RNA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21).
    Kozu T; Sueoka E; Okabe S; Sueoka N; Komori A; Fujiki H
    Biochimie; 1996; 78(11-12):1067-73. PubMed ID: 9150886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis.
    Shimada H; Ichikawa H; Ohki M
    Leukemia; 2002 May; 16(5):874-85. PubMed ID: 11986950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
    Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
    Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon.
    Shimizu K; Kitabayashi I; Kamada N; Abe T; Maseki N; Suzukawa K; Ohki M
    Blood; 2000 Jul; 96(1):288-96. PubMed ID: 10891464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21).
    Tobal K; Yin JA
    Blood; 1996 Nov; 88(10):3704-9. PubMed ID: 8916934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leukaemia.
    Maeda M; Otsuka T; Kimura N; Kozu T; Fukuyama T; Uchida N; Sugio Y; Itoh Y; Iino T; Inaba S; Niho Y
    Br J Haematol; 2000 Nov; 111(2):570-9. PubMed ID: 11122105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.
    Berg T; Fliegauf M; Burger J; Staege MS; Liu S; Martinez N; Heidenreich O; Burdach S; Haferlach T; Werner MH; Lübbert M
    Haematologica; 2008 Nov; 93(11):1728-33. PubMed ID: 18790797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.
    Liu S; Shen T; Huynh L; Klisovic MI; Rush LJ; Ford JL; Yu J; Becknell B; Li Y; Liu C; Vukosavljevic T; Whitman SP; Chang KS; Byrd JC; Perrotti D; Plass C; Marcucci G
    Cancer Res; 2005 Feb; 65(4):1277-84. PubMed ID: 15735013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission.
    Satake N; Maseki N; Kozu T; Sakashita A; Kobayashi H; Sakurai M; Ohki M; Kaneko Y
    Br J Haematol; 1995 Dec; 91(4):892-8. PubMed ID: 8547135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
    Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8.
    Fukuyama T; Kitamura T; Kozu T
    Int J Hematol; 2022 May; 115(5):686-693. PubMed ID: 35152350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide.
    Sakakura C; Yamaguchi-Iwai Y; Satake M; Bae SC; Takahashi A; Ogawa E; Hagiwara A; Takahashi T; Murakami A; Makino K
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11723-7. PubMed ID: 7972130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.
    Higuchi M; O'Brien D; Kumaravelu P; Lenny N; Yeoh EJ; Downing JR
    Cancer Cell; 2002 Feb; 1(1):63-74. PubMed ID: 12086889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.